SITE001-0026

SITE001 (USA) › SITE001-0026

SITE001-0026

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE001 (USA) · Dr. Reyes
consented 2025-09-20

completed

AEs

3

Serious

1

Dropout signal

–

Adverse events

3

Grade 2 Stomatitis — outcome: RECOVERED/RESOLVED; onset 2022-04-25 (study day 26); relationship: not assessed

moderate assessed

Grade 2 Nausea — outcome: RECOVERED/RESOLVED; onset 2022-04-11 (study day 12); relationship: NOT RELATED

moderate assessed

Grade 3 Alopecia — outcome: RECOVERED/RESOLVED; onset 2022-04-11 (study day 12); relationship: not assessed; serious criteria: hospitalization

severe serious assessed

Data queries

0

No data queries. Open queries would appear here for this patient.